Visior is a clinical-stage medical device company that has introduced a commercial video-based noninvasive delivery of visual and auditory stimulation, via respective pathways, for inducing changes in cerebral blood flow, brain perfusion, retinal blood flow, retinal perfusion, and reconstruction of neural connectivity in the visual system at large. The stimulation is intended to complement medication treatment modalities and enable new treatment modalities as well as drug delivery for neurodegenerative conditions.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Visior Technologies Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jan 2, 2019
bjo.bmj.com
Effects of image brightness and contrast dynamic altering stimuli (DAS) when viewing video content on ocular blood flow
undefined
Jan 1, 2018
www.ncbi.nlm.nih.gov
Home use of binocular dichoptic video content device for treatment of amblyopia: a pilot study - PubMed
undefined
Feb 23, 2017
www.israel21c.org
Kids like this fun treatment for lazy eye with no patches